UK markets open in 56 minutes

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.8600-0.0500 (-1.72%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
0
0
0
0
0
Operating expenses
Research development
9,194
6,608
6,645
4,210
2,328
Selling general and administrative
9,075
7,999
10,620
7,224
4,859
Total operating expenses
18,269
14,607
17,265
11,434
7,187
Operating income or loss
-18,269
-14,607
-17,265
-11,434
-7,187
Interest expense
-
-
-
-
192.817
Total other income/expenses net
-2,344
-2,282
25.648
29.299
-742.308
Income before tax
-21,552
-17,828
-17,240
-11,405
-8,123
Income tax expense
0
0
0
-
-
Income from continuing operations
-21,552
-17,828
-17,240
-11,405
-8,123
Net income
-21,552
-17,828
-17,240
-11,405
-8,123
Net income available to common shareholders
-26,055
-22,331
-17,240
-22,884
-10,691
Basic EPS
-
-1.97
-2.03
-5.50
-10.92
Diluted EPS
-
-1.97
-2.03
-5.50
-10.92
Basic average shares
-
11,309
8,497
4,158
974.768
Diluted average shares
-
11,309
8,497
4,158
974.768
EBITDA
-
-14,561
-17,213
-11,390
-7,801